---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-007428"
form_type: "8-K"
ticker: "PBSV"
cik: "0001304161"
company_name: "Pharma-Bio Serv, Inc."
filed_at: "2023-05-31T23:59:59+00:00"
generated_at: "2026-06-14T10:15:54.503387+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Pharma-Bio Serv elects Irving Wiesen as Class I director at 2023 annual meeting

## Summary
- Irving Wiesen elected Class I director with 7,477,036 for and 11,696,947 withheld; 515,852 broker non-votes.
- Ratification of Crowe PR PSC as auditor for FY ending Oct 31, 2023 passed with 14,344,226 for, 1,492,688 against, 3,852,921 abstain.
- Withheld votes exceeded for votes in director election; elected by plurality rule.

## SEC filing metadata
- accession: 0001654954-23-007428
- form_type: 8-K
- ticker: PBSV
- cik: 0001304161
- company_name: Pharma-Bio Serv, Inc.
- filed_at: 2023-05-31T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1304161/000165495423007428/0001654954-23-007428-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1304161/000165495423007428/pbsv_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-007428
- JSON: https://secwatch.observer/filing/0001654954-23-007428.json
- Plain text: https://secwatch.observer/filing/0001654954-23-007428.txt

## Key facts
- Shareholder Votes
  Pharma-Bio Serv, Inc. shareholders approved Ratification of Crowe PR PSC as independent auditors at the 2023-05-31 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-05-31
  source text: The ratification of the selection of Crowe PR PSC as the Company's independent certified public accountants for the fiscal year ending October 31, 2023 received the following votes: Votes For Votes Against Abstain 14,344,226 1,492,688 3,852,921 There were no broker non-votes on this proposal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1304161/000165495423007428/0001654954-23-007428-index.htm
- Shareholder Votes
  Pharma-Bio Serv, Inc. shareholders approved Election of Irving Wiesen as a Class I director at the 2023-05-31 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-05-31
  source text: Irving Wiesen was elected as a Class I director by a plurality of the shares present in person or represented by proxy at the Annual Meeting and entitled to vote. Mr. Wiesen shall serve as a Class I director until the 2026 Annual Meeting of Stockholders or until his successor is duly elected and qualified. The votes for this proposal were as follows: Nominee Votes For Votes Withheld Irving Wiesen 7,477,036 11,696,947 There were 515,852 broker non-votes on this proposal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1304161/000165495423007428/0001654954-23-007428-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.